Swiss Study on Subarachnoid Hemorrhage

NCT03245866 · tracked via the Priya Life Science Switzerland tracker

Sponsor

University Hospital, Geneva

Phase

Observational

Started

2009-01-01

Last updated

2023-05-16

Condition(s) studied

Subarachnoid HemorrhageIntracranial Aneurysm

Investigational drug(s) / intervention(s)

Observational/ no intervention

Study summary

This registry was created to assess management parameters of patients treated for aneurysmal subarachnoid hemorrhage in Switzerland. All Swiss hospitals with a neurosurgery department, an intensive care unit and an interventional neuroradiology team that treat neurovascular emergencies participate in the registry. Clinical parameters are entered into a common database. This database will provide (1) a nationwide assessment of the current standard of care and (2) the outcomes for patients in Switzerland including neuropsychological assessments.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion criteria: \- Patients admitted with a proven diagnosis of aneurysmal subarachnoid hemorrhage. Exclusion criteria: \- Patients in whom the source of haemorrhage could not be identified (angiogram-negative SAH) or SAH with other causes than cerebral aneurysms.

Primary outcome measure(s)

Functional outcome as assessed by the modified Rankin scale — 5 years after hemorrhage
The modified Rankin scale is used to represent the level of disability and is divided into 7 categories (0-6). The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.

Trial sites (9)

Facility	City	Region	Status
Kantonsspital Aarau	Aarau	Canton of Aargau	Recruiting
Geneva University Hospital	Geneva	Canton of Geneva	Recruiting
Kantonsspital St. Gallen	Sankt Gallen	Canton of St. Gallen	Recruiting
University Hospital Basel	Basel	Switzerland	Recruiting
University Hospital Bern	Bern	Switzerland	Recruiting
University Hospital Lausanne	Lausanne	Switzerland	Recruiting
Luzerner Kanton Spital	Lucerne	Switzerland	Recruiting
Ospedale Civico	Lugano	Switzerland	Recruiting
University Hospital Zürich	Zurich	Switzerland	Recruiting

More University Hospital, Geneva trials in Switzerland

Genetic Risks for Childhood Cancer Complications in Switzerland Recruiting

Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment Recruiting

Anhydroglucitol in Children With Type 1 Diabetes Recruiting

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms Recruiting

Hyperbaric Oxygen Therapy to Improve Autologous Fat Graft Intake in Irradiated Breast Recruiting

Other trials for the same condition

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms Recruiting

International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach Active, not recruiting

Neurovascular Product Surveillance Registry Recruiting

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03245866 on ClinicalTrials.gov ↗ ← All trials in Switzerland